Premium
Commentary: tenofovir is superior to entecavir in HBeAg‐positive chronic hepatitis B patients – authors' reply
Author(s) -
Gao L.,
Trinh H. N.,
Li J.,
Nguyen M. H.
Publication year - 2014
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.12708
Subject(s) - entecavir , tenofovir , medicine , chronic hepatitis , hbeag , gastroenterology , virology , hepatitis b , population , prospective cohort study , hepatitis b virus , virus , lamivudine , hbsag , environmental health , human immunodeficiency virus (hiv)